Its efficacy will be assessed in a double-blind, randomized, placebo-controlled trial for patients with active class III and IV lupus nephritis (NCT03385564)
-Synuclein interferes with synaptic vesicle trafficking, mitochondrial dynamics, and axonal transport, ultimately leading to synaptic dysfunction, impaired neurotransmission, and axonopathy
The major detoxification pathway of 4HNE involves GSTs 16
The primary purpose of the National Institute for Occupational Safety and Health (NIOSH) Hazardous Drug List is to provide information to healthcare professionals to ensure appropriate protective measures are being employed to prevent exposure to drugs and other chemicals on the job
Designed solely for parenteral use (drug administration by intravenous, intramuscular, or subcutaneous injection) following the addition of drugs that require dilution or
Free consulting service 6